Enfusion (ENFN) Competitors

Enfusion (NYSE:ENFN) and Zeta Global (NASDAQ:ZETA) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Which has higher valuation and earnings, ENFN or ZETA?

Enfusion has higher earnings, but lower revenue than Zeta Global. Zeta Global is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enfusion	$181.62M	6.84	$6.03M	$0.03	323.33
Zeta Global	$766.07M	6.11	-$187.48M	-$1.06	-20.19

Does the MarketBeat Community prefer ENFN or ZETA?

Zeta Global received 38 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 58.02% of users gave Zeta Global an outperform vote while only 18.75% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
Enfusion	Outperform Votes 9 18.75%	Underperform Votes 39 81.25%
Zeta Global	Outperform Votes 47 58.02%	Underperform Votes 34 41.98%

Which has more risk and volatility, ENFN or ZETA?

Enfusion has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Zeta Global has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

Is ENFN or ZETA more profitable?

Enfusion has a net margin of 1.40% compared to Zeta Global's net margin of -22.20%. Enfusion's return on equity of 6.60% beat Zeta Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enfusion	1.40%	6.60%	4.86%
Zeta Global	-22.20%	-101.48%	-31.80%

Do insiders and institutionals hold more shares of ENFN or ZETA?

81.1% of Enfusion shares are owned by institutional investors. Comparatively, 75.8% of Zeta Global shares are owned by institutional investors. 36.4% of Enfusion shares are owned by insiders. Comparatively, 25.5% of Zeta Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to ENFN or ZETA?

In the previous week, Zeta Global had 7 more articles in the media than Enfusion. MarketBeat recorded 11 mentions for Zeta Global and 4 mentions for Enfusion. Zeta Global's average media sentiment score of 0.70 beat Enfusion's score of 0.09 indicating that Zeta Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enfusion	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zeta Global	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend ENFN or ZETA?

Enfusion presently has a consensus target price of $9.33, suggesting a potential downside of 3.78%. Zeta Global has a consensus target price of $21.42, suggesting a potential upside of 0.08%. Given Zeta Global's stronger consensus rating and higher probable upside, analysts plainly believe Zeta Global is more favorable than Enfusion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enfusion	3 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Zeta Global	0 Sell rating(s)	0 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	3.07

Summary

Zeta Global beats Enfusion on 10 of the 19 factors compared between the two stocks.